Recent findings on the role of fungal products in the treatment of cancer
Clin. transl. oncol. (Print)
; 23(2): 197-204, feb. 2021. ilus
Artigo
em Inglês
| IBECS
| ID: ibc-220603
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
In modern medicine, natural products have aided humans against their battles with cancer. Among these products, microorganisms, medicinal herbs and marine organisms are considered to be of great benefit. In recent decades, more than 30 fungal immunity proteins have been identified and proved to be extractable from a wide range of fungi, including mushrooms. Although chemotherapy is used to overcome cancer cells, the side effects of this method are of great concern in clinical practice. Fungal products and their derivatives constitute more than 50% of the clinical drugs currently being used globally. Approximately 60% of the clinically approved drugs for cancer treatment have natural roots. Anti-tumor immunotherapy is prospective with a rapidly growing market worldwide due to its high efficiency, immunity, and profit. Polysaccharide extracts from natural sources are being used in clinical and therapeutic trials on cancer patients. This review aims to present the latest findings in cancer treatment through isolated and extraction of fungal derivatives and other natural biomaterials (AU)
Buscar no Google
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Produtos Biológicos
/
Fungos
/
Neoplasias
/
Antineoplásicos
Limite:
Humanos
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2021
Tipo de documento:
Artigo
Instituição/País de afiliação:
Bayero University/Nigeria
/
Hamedan University of Medical Sciences/Iran
/
Iran University of Medical Sciences/Iran
/
Islamic Azad University/Iran
/
Lorestan University of Medical Sciences/Iran
/
Tehran University of Medical Sciences/Iran